For immediate release: January 25, 2007
The University of Maryland School of Medicine Department of Pharmacology hosted a reception to honor Professor Angela Brodie on her winning of the General Motors Charles F. Kettering Prize for cancer research. The award recognized Dr. Brodie's pioneering work in developing aromatase inhibitors, a new class of drugs widely used today to treat breast cancer. Dr. Brodie is professor of pharmacology and experimental therapeutics at the University of Maryland School of Medicine and a University of Maryland Greenebaum Cancer Center researcher.
Dr. Bruce E. Jarrell, Vice Dean for Academic Affairs in the University of Maryland School of Medicine, Dr. Edson Albuquerque, professor and chairman of the Department of Pharmacology in the University of Maryland School of Medicine, and Dr. Kevin Cullen, director of the University of Maryland Greenebaum Cancer Center, gave remarks about the significance and impact of Dr. Brodie's work. Faculty, staff and students attended the celebration to congratulate Dr. Brodie on her well-deserved award.
Read more about Dr. Brodie's Kettering Prize and her ground-breaking research.